Non Hodgkin Lymphoma Clinical Trial

Clinical Trial Finder Non Hodgkin Lymphoma Trials

Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877

See Locations Near You

Summary

This study has two parts (A and B). The primary purpose of Part A is to find the maximum tolerated dose is for an experimental drug called AZD4877 based on the side effects experienced by patients that receive AZD4877 on a twice a week basis. For Part B, an additional 20 patients will be treated at the maximum dose identified in Part A. AZD4877 is an Eg5 or Kinesin Spindle Protein inhibitor that interferes with tumor cell division leading to tumor growth

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Part A: Advanced solid tumors (including lymphoma without bone marrow involvement) for which standard treatment doesn't exist or is no longer effective.
Part B: B-cell non-Hodgkin lymphoma that is not eligible for curative therapy or has relapsed.
Relatively good overall health other than your cancer

Exclusion Criteria:

Poor bone marrow function (not producing enough blood cells). Serious heart conditions. Poor liver or kidney function

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 1

Estimated Enrollment:

44

Study ID:

NCT00471367

Recruitment Status:

Terminated

Sponsor:

AstraZeneca

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Research Site
New York New York, , United States
Research Site
Philadelphia Pennsylvania, , United States
Research Site
Greenville South Carolina, , United States

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 1

Estimated Enrollment:

44

Study ID:

NCT00471367

Recruitment Status:

Terminated

Sponsor:


AstraZeneca

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
Clinical Trials Test State-of-the-Art Cancer Treatments
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider